<?xml version="1.0" encoding="UTF-8"?>
<sec id="Sec4" class="sec">
 <div class="title" xmlns="http://www.w3.org/1999/xhtml">Pembrolizumab heavy-chain/PD-1 receptor interaction energy</div>
 <p id="Par15" xmlns="http://www.w3.org/1999/xhtml">Among the 408 residue-residue pairs analyzed here, 260 were pembrolizumab heavy-chain/PD-1 interactions. It is a reflection of the proximity between the HC/LC pembrolizumab with the receptor PD-1 represented in crystallographic structures, where pembrolizumab 
  <sub>
   <span class="italic">Fab</span>
  </sub> heavy-chain fragment is closer to the PD-1 receptor than the light-chain one
  <span class="sup">
   <a ref-type="bibr" rid="CR26" href="#CR26">26</a>,
   <a ref-type="bibr" rid="CR30" href="#CR30">30</a>
  </span>. Besides a higher number of pairs, the sum of the energetic interaction between the pembrolizumab heavy-chain and the PD-1 receptor amino-acids shows also the higher value, accounting for -142.50 kcal mol
  <span class="sup">−1</span> (−138.33 kcal mol
  <span class="sup">−1</span>) for the dielectric constant 
  <span class="italic">ε</span>
  <sub>20</sub> (
  <span class="italic">ε</span>
  <sub>40</sub>).
 </p>
 <p id="Par16" xmlns="http://www.w3.org/1999/xhtml">Although 
  <span class="italic">Y</span>33
  <sub>
   <span class="italic">HC</span>
  </sub> has been shown to be the most energetic pembrolizumab amino-acid residue, it only interacts with 15 residues from the PD-1 receptor. Figure 
  <a rid="Fig4" ref-type="fig" href="#Fig4">4a</a> depicts the highest interaction energies calculated to 
  <span class="italic">Y</span>33
  <sub>
   <span class="italic">HC</span>
  </sub>/PD-1 residues. As one can see, the strongest energy of 
  <span class="italic">Y</span>33
  <sub>
   <span class="italic">HC</span>
  </sub> is mainly related to its binding with three residues: 
  <span class="italic">K</span>78 (
  <span class="italic">ε</span>
  <sub>20</sub>: −12.42 kcal mol
  <span class="sup">−1</span>; 
  <span class="italic">ε</span>
  <sub>40</sub>: −11.99 kcal mol
  <span class="sup">−1</span>), 
  <span class="italic">Q</span>88 (
  <span class="italic">ε</span>
  <sub>20</sub>: −4.45 kcal mol
  <span class="sup">−1</span>; 
  <span class="italic">ε</span>
  <sub>40</sub>: −4.51 kcal mol
  <span class="sup">−1</span>) and 
  <span class="italic">P</span>89 (
  <span class="italic">ε</span>
  <sub>20</sub>: −3.17 kcal mol
  <span class="sup">−1</span>; 
  <span class="italic">ε</span>
  <sub>40</sub>: −3.15 kcal mol
  <span class="sup">−1</span>). Meanwhile, 
  <span class="italic">Y</span>101
  <sub>
   <span class="italic">HC</span>
  </sub>, 
  <span class="italic">R</span>102
  <sub>
   <span class="italic">HC</span>
  </sub> and 
  <span class="italic">Y</span>103
  <sub>
   <span class="italic">HC</span>
  </sub> are involved with 23, 30 and 21 pairs, respectively. As shown in Fig. 
  <a rid="Fig4" ref-type="fig" href="#Fig4">4b</a>, 
  <span class="italic">Y</span>101
  <sub>
   <span class="italic">HC</span>
  </sub> has its most intense interaction with the residue 
  <span class="italic">K</span>78 (
  <span class="italic">ε</span>
  <sub>20</sub>: −9.43 kcal mol
  <span class="sup">−1</span>; 
  <span class="italic">ε</span>
  <sub>40</sub>: −8.92 kcal mol
  <span class="sup">−1</span>), being followed by the residue 
  <span class="italic">T</span>76 (
  <span class="italic">ε</span>
  <sub>20</sub>: −4.82 kcal mol
  <span class="sup">−1</span>; 
  <span class="italic">ε</span>
  <sub>40</sub>: −4.71 kcal mol
  <span class="sup">−1</span>). The residue 
  <span class="italic">R</span>102
  <sub>
   <span class="italic">HC</span>
  </sub> does not show a strong individual interaction with none of the PD-1 residues (Fig. 
  <a rid="Fig4" ref-type="fig" href="#Fig4">4c</a>), its high binding energy being due to a number of minor energies contributions, including those from the residues 
  <span class="italic">A</span>132 (
  <span class="italic">ε</span>
  <sub>20</sub>: −3.84 kcal mol
  <span class="sup">−1</span>; 
  <span class="italic">ε</span>
  <sub>40</sub>: −3.44 kcal mol
  <span class="sup">−1</span>), 
  <span class="italic">I</span>126 (
  <span class="italic">ε</span>
  <sub>20</sub>: −2.71 kcal mol
  <span class="sup">−1</span>; 
  <span class="italic">ε</span>
  <sub>40</sub>: −2.87 kcal mol
  <span class="sup">−1</span>), 
  <span class="italic">K</span>78 (
  <span class="italic">ε</span>
  <sub>20</sub>: −2.43 kcal mol
  <span class="sup">−1</span>; 
  <span class="italic">ε</span>
  <sub>40</sub>: −3.12 kcal mol
  <span class="sup">−1</span>) and 
  <span class="italic">N</span>66 (
  <span class="italic">ε</span>
  <sub>20</sub>: −2.53 kcal mol
  <span class="sup">−1</span>; 
  <span class="italic">ε</span>
  <sub>40</sub>: −2.17 kcal mol
  <span class="sup">−1</span>). Similar to 
  <span class="italic">R</span>102, 
  <span class="italic">Y</span>103
  <sub>
   <span class="italic">HC</span>
  </sub> binding energy is composed by the sum of a number of small interactions (Fig. 
  <a rid="Fig4" ref-type="fig" href="#Fig4">4d</a>), with the strongest being associated with the residue 
  <span class="italic">V</span>64 (
  <span class="italic">ε</span>
  <sub>20</sub>: −3.49 kcal mol
  <span class="sup">−1</span>; 
  <span class="italic">ε</span>
  <sub>40</sub>: −3.49 kcal mol
  <span class="sup">−1</span>).
  <div id="Fig4" class="fig">
   <span class="label">Figure 4</span>
   <div class="caption">
    <p>Graphical panel presenting the most relevant interactions involving the pembrolizumab heavy-chain residues. (
     <span class="bold">a</span>) 
     <span class="italic">Y</span>33 and 
     <span class="italic">Y</span>35; (
     <span class="bold">b</span>) 
     <span class="italic">R</span>99, 
     <span class="italic">D</span>100 and 
     <span class="italic">Y</span>101; (
     <span class="bold">c</span>) 
     <span class="italic">R</span>102 and (
     <span class="bold">d</span>) 
     <span class="italic">F</span>103, 
     <span class="italic">M</span>105 and 
     <span class="italic">D</span>108, respectively.
    </p>
   </div>
   <div xlink:href="41598_2018_20325_Fig4_HTML" id="d29e1180" class="graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
  </div>
 </p>
 <p id="Par17" xmlns="http://www.w3.org/1999/xhtml">Figure 
  <a rid="Fig5" ref-type="fig" href="#Fig5">5a</a> displays how close the residues 
  <span class="italic">Y</span>33
  <sub>
   <span class="italic">HC</span>
  </sub>, 
  <span class="italic">Y</span>101
  <sub>
   <span class="italic">HC</span>
  </sub>, 
  <span class="italic">R</span>102
  <sub>
   <span class="italic">HC</span>
  </sub> and 
  <span class="italic">Y</span>103
  <sub>
   <span class="italic">HC</span>
  </sub> are to the PD-1 receptor. Analyzing it one can understand the reason why these amino-acids present some of the largest number of pair-interaction and binding energies. All of them are involved in a network of hydrogen bonds with the PD-1 residues from CC’FG 
  <span class="italic">β</span>-strands and some of its loops, mainly those belonging to the C’D loop, which was described to intrude into the complementary determining region (CDR) of the pembrolizumab drug, a variable portion present in some igG molecules responsible for the recognition of specific antigens
  <span class="sup">
   <a ref-type="bibr" rid="CR30" href="#CR30">30</a>
  </span>. Figure 
  <a rid="Fig5" ref-type="fig" href="#Fig5">5b</a> depicts some of these interactions, starting with the residue 
  <span class="italic">Y</span>33
  <sub>
   <span class="italic">HC</span>
  </sub>. Here one can see that it forms two direct hydrogen bonds with the residues 
  <span class="italic">K</span>78 charged amine group and 
  <span class="italic">Q</span>88 side-chain oxygen. Besides, the residue 
  <span class="italic">Y</span>33
  <sub>
   <span class="italic">HC</span>
  </sub> also makes a water-mediated hydrogen bond with the 
  <span class="italic">K</span>78 carbonyl group of the main-chain, and is involved in non-polar contacts with 
  <span class="italic">P</span>89. The two hydrogen bonds between the residues 
  <span class="italic">Y</span>33
  <sub>
   <span class="italic">HC</span>
  </sub>-
  <span class="italic">K</span>78 give the major contribution to their high energy.
  <div id="Fig5" class="fig">
   <span class="label">Figure 5</span>
   <div class="caption">
    <p>Intermolecular interactions of the most energetic pembrolizumab heavy-chain residues. (
     <span class="bold">a</span>) Structural representation of the residues 
     <span class="italic">Y</span>33
     <sub>
      <span class="italic">HC</span>
     </sub>, 
     <span class="italic">Y</span>101
     <sub>
      <span class="italic">HC</span>
     </sub>, 
     <span class="italic">R</span>102
     <sub>
      <span class="italic">HC</span>
     </sub> and 
     <span class="italic">F</span>103
     <sub>
      <span class="italic">HC</span>
     </sub> within the PD-1 binding site. (
     <span class="bold">b</span>)–(
     <span class="bold">f</span>) Interaction of these amino-acids with the most relevant residues of the receptor PD-1, respectively. Dashed lines in light blue (purple) (marine) represent direct (water-mediated) (non-conventional) hydrogen bonds, and the green lines represent 
     <span class="italic">σ</span>-
     <span class="italic">π</span> interactions.
    </p>
   </div>
   <div xlink:href="41598_2018_20325_Fig5_HTML" id="d29e1317" class="graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
  </div>
 </p>
 <p id="Par18" xmlns="http://www.w3.org/1999/xhtml">The residues 
  <span class="italic">Y</span>101
  <sub>
   <span class="italic">HC</span>
  </sub>, 
  <span class="italic">R</span>102
  <sub>
   <span class="italic">HC</span>
  </sub> and 
  <span class="italic">Y</span>103
  <sub>
   <span class="italic">HC</span>
  </sub> interaction network is shown in Fig. 
  <a rid="Fig5" ref-type="fig" href="#Fig5">5c–e</a>. Figure 
  <a rid="Fig5" ref-type="fig" href="#Fig5">5c</a> depicts 3 directs, 2 water-mediated and 1 non-conventional hydrogen bonds. The strongest interaction of this residue is related to the pair 
  <span class="italic">Y</span>101
  <sub>
   <span class="italic">HC</span>
  </sub>-
  <span class="italic">K</span>78, where it creates a direct hydrogen bond with charged side-chain amine and a non-conventional hydrogen bond with amine of the main-chain. Three hydrogen bonds are formed with the residue 
  <span class="italic">T</span>76, two with its oxygen atoms (carbonyl and hydroxyl) and a water-mediated with the hydroxyl group. It is also involved in one wHB with the residue Y68 side-chain hydroxyl and in some non-polar contacts with the residues 
  <span class="italic">D</span>77 and 
  <span class="italic">N</span>66. The residues 
  <span class="italic">R</span>102
  <sub>
   <span class="italic">HC</span>
  </sub> and 
  <span class="italic">Y</span>103
  <sub>
   <span class="italic">HC</span>
  </sub> are mainly involved in weak interactions. The latter form a 
  <span class="italic">σ</span>-
  <span class="italic">π</span> interaction with the residue 
  <span class="italic">V</span>64, a non-conventional hydrogen bond with the residue 
  <span class="italic">P</span>83 and some non-polar contacts with the residues 
  <span class="italic">L</span>128 and 
  <span class="italic">D</span>85, while the former makes hydrogen bonds with 
  <span class="italic">A</span>132 oxygen atom and 
  <span class="italic">N</span>66 side-chain nitrogen, besides non-conventional hydrogen bonds with the side-chain of the residues 
  <span class="italic">I</span>126 and 
  <span class="italic">K</span>78.
 </p>
 <p id="Par19" xmlns="http://www.w3.org/1999/xhtml">The MFCC scheme yields not only the individual pembrolizumab/PD-1 interactions but also important information from the pair-interactions that could be otherwise missing, namely: 
  <span class="italic">R</span>99
  <sub>
   <span class="italic">HC</span>
  </sub>-
  <span class="italic">D</span>85 (
  <span class="italic">ε</span>
  <sub>20</sub>: −9.75 kcal mol
  <span class="sup">−1</span>; 
  <span class="italic">ε</span>
  <sub>40</sub>: −7.43 kcal mol
  <span class="sup">−1</span>), 
  <span class="italic">Y</span>35
  <sub>
   <span class="italic">HC</span>
  </sub>-
  <span class="italic">S</span>87 (
  <span class="italic">ε</span>
  <sub>20</sub>: −2.13 kcal mol
  <span class="sup">−1</span>; 
  <span class="italic">ε</span>
  <sub>40</sub>: −2.08 kcal mol
  <span class="sup">−1</span>), 
  <span class="italic">M</span>105
  <sub>
   <span class="italic">HC</span>
  </sub>-
  <span class="italic">K</span>131 (
  <span class="italic">ε</span>
  <sub>20</sub>: −6.61 kcal mol
  <span class="sup">−1</span>; 
  <span class="italic">ε</span>
  <sub>40</sub>: −6.06 kcal mol
  <span class="sup">−1</span>), and 
  <span class="italic">D</span>108
  <sub>
   <span class="italic">HC</span>
  </sub>-
  <span class="italic">K</span>131 (
  <span class="italic">ε</span>
  <sub>20</sub>: −6.56 kcal mol
  <span class="sup">−1</span>; 
  <span class="italic">ε</span>
  <sub>40</sub>: −4.82 kcal mol
  <span class="sup">−1</span>).
 </p>
 <p id="Par20" xmlns="http://www.w3.org/1999/xhtml">The residues 
  <span class="italic">M</span>105
  <sub>
   <span class="italic">HC</span>
  </sub> and 
  <span class="italic">D</span>108
  <sub>
   <span class="italic">HC</span>
  </sub> make hydrogen bonds with the residue 
  <span class="italic">K</span>131. The main-chain oxygen carbonyl of 
  <span class="italic">M</span>105
  <sub>
   <span class="italic">HC</span>
  </sub> makes a direct hydrogen bonds with the charged amine of this lysine residue, while the residue D108 is engaged in a water-mediated hydrogen bond with the same molecular group, yet presenting its negatively charged carboxyl group (
  <span class="italic">D</span>108) in a closer distance to positively charged amine group (see Fig. 
  <a rid="Fig5" ref-type="fig" href="#Fig5">5f</a>). The pair 
  <span class="italic">Y</span>35
  <sub>
   <span class="italic">HC</span>
  </sub>-
  <span class="italic">S</span>87 binding energy is governed by a hydrogen bond formed between the hydroxyl group of this tyrosine residue (
  <span class="italic">Y</span>35
  <sub>
   <span class="italic">HC</span>
  </sub>) and the main-chain carbonyl from 
  <span class="italic">S</span>87. The pair 
  <span class="italic">R</span>99
  <sub>
   <span class="italic">HC</span>
  </sub>-
  <span class="italic">D</span>85 is described for some authors as the only salt bridge formed between the pembrolizumab drug and the PD-1 receptor
  <span class="sup">
   <a ref-type="bibr" rid="CR26" href="#CR26">26</a>,
   <a ref-type="bibr" rid="CR30" href="#CR30">30</a>
  </span>.
 </p>
</sec>
